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Abstract
We investigated the effect of the specific L3-adrenergic receptor agonist CL 316,243 (CL) on proliferation and functional
differentiation of the Siberian hamster (Phodopus sungorus) white and brown preadipocytes in primary cell culture.
Proliferation of both white and brown preadipocytes was stimulated by a general L-adrenergic agonist (isoproterenol) but not
by CL. Lipolysis of differentiated white and brown adipocytes was stimulated similarly by CL with maximum effect at 10
nM. Thermogenic properties of cells were assessed by immunodetection of UCP-1, the brown adipocyte specific uncoupling
protein, and measurement of cytochrome c oxidase (COx) activity as an index of mitochondrial capacity. UCP-1 content was
largely increased by CL in BAT but not in WAT cultures. Basal UCP-2 mRNA levels were similar in WAT and BAT cultures
and increased by both CL and isoproterenol. COx activity of BAT cultures was twice as high as that of WAT cultures but in
neither cell culture system could it be increased by L-adrenergic stimulation. We suggest (i) that white and brown
preadipocyte proliferation is increased in vitro via L1 or L2, but not L3-adrenergic pathways, (ii) that white and brown
preadipocytes represent different cell types, and (iii) that in vitro L-adrenergic stimulation it is not sufficient to induce
complete thermogenic adaptation of brown adipocytes. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
White (WAT) and brown adipose tissue (BAT)
have opposite functions in mammalian energy me-
tabolism, i.e., that of energy storage and energy dis-
sipation, respectively. Brown adipose tissue (BAT) is
a thermogenic tissue and its heat production is
acutely activated by the sympathetic nervous system.
The thermogenic function of brown adipocytes is
mainly manifest by their high mitochondrial density
and expression of the uncoupling protein UCP-1
which is still the only known exclusive molecular
marker for brown adipocytes [1]. Morphologically,
white and brown adipose tissue can be distinguished
rather easily by their di¡erent appearance and ana-
tomical distribution. White and brown adipocytes
are also recognised as two distinct cell types with
opposing functions in energy metabolism. However,
on a molecular level, white and brown adipocytes
share many characteristics, especially regarding con-
trol of lipogenesis and lipolytical properties [2]. Both
white and brown adipocytes are equipped with L3-
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adrenergic receptors (L3-ARs) [3] and activation of
BAT thermogenesis and thus increased energy expen-
diture is mainly under control of the sympathetic
nervous system acting through L3-ARs [4]. Targeted
disruption of the L3-AR in mice led to a gradual
increase in body fat, demonstrating a role of this
receptor in energy homeostasis [5,6]. Speci¢c L3-ad-
renergic agonists are considered as potential agents
in the treatment of human obesity [7].
CL 316,243 (disodium(R,R)-5-[2-[2-(3-chlorophen-
yl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-
2,2-dicarboxylate) is a potent L-adrenergic agonist
highly speci¢c for rodent L3-ARs [8]. An anti obesity
e¡ect of chronic CL 316,243 (CL) treatment was
shown in several rodent models of obesity [9^14].
In these in vivo experiments CL treatment had di¡er-
ent e¡ects on WAT and BAT, respectively. Whereas
in BAT hypertrophy and activation of thermogenesis
was induced, white fat depots were reduced through
a reduction of size and number of white fat cells [11].
Acute or long-term treatment of mice and rats with
CL led to an increase in energy expenditure, an in-
crease in insulin levels and secretion (acute treat-
ment) or insulin action (long-term treatment), and
a reduction in food intake [14^17]. For these e¡ects
the presence of L3-ARs in both BAT and WAT is
apparently required (and su⁄cient), as demonstrated
in an elegant study using transgenic and gene knock-
out mice [16].
Although direct e¡ects of CL on white and brown
adipocytes, respectively, have been demonstrated, to
our knowledge there are no comparative studies per-
formed in parallel on white and brown preadipocyte
cultures from the same source. We have developed a
primary cell culture system allowing the comparative
investigation of functional di¡erentiation in white
and brown adipocytes, respectively [18]. Here we
used this culture system to investigate the e¡ect of
the CL on proliferation, functional di¡erentiation
and energy metabolism of white and brown preadi-
pocytes in primary cell cultures.
2. Material and methods
2.1. Primary cell culture
Cell culture was performed as described before
[18,19]. The inguinal white fat and several depots
of brown fat (axillar, suprasternal, interscapular,
dorsal-cervical) from Siberian hamsters (Phodopus
sungorus) aged 4^6 weeks were used for the compa-
rative WAT and BAT cultures. For every cell cul-
ture, fat depots of 4^6 animals were pooled. The
stromal-vascular fraction was obtained after collage-
nase treatment as described [19]. Cells were inoculat-
ed in petri dishes or multiwell plates at approxi-
mately 1500^2000 cells/cm2. Cells were grown at
37‡C in air with 5% CO2 content and 100% relative
humidity in cell culture medium (50% modi¢ed Ea-
gle’s medium (Gibco/BRL) and 50% F12 Ham’s F12
medium (Gibco/BRL) supplemented with NaHCO3
(1.2 g/l), biotin (4 mg/l), Ca-panthotenate (2 mg/l),
glutamine (5 mM), glucose (4.5 g/l) and HEPES (15
mM, pH 7.4), penicillin G (6.25 mg/l), and strepto-
mycin (5 mg/l). Until the third day of culture, the
medium was supplemented with 10% foetal calf se-
rum (FCS), and on day 3 it was changed to 7% FCS.
Medium was changed at days 1 and 3. Seventeen nM
insulin and 1 nM triiodothyronine (T3) were added
at day 3.
2.2. Analyses
For determination of cell number, cells grown in
12-well multiwell dishes were trypsinised and sus-
pended in 200 Wl PBS bu¡er. Cells were counted us-
ing a Thoma counting chamber. This was performed
in parallel to the other experiments in order to nor-
malise the results for cell number.
UCP-1 content was determined by Western blot
analysis as described before [18] using an enhanced
chemoluminescence (ECL) Western blotting detec-
tion system (Amersham, Germany). mRNA extrac-
tion and Northern blots were performed as described
previously [19]. UCP-1 and UCP-2 probes from rat
(kindly provided by Dr Daniel Ricquier) were used
for hybridisation. Quantitation of signals was per-
formed using a phosphoimager (BAS2000, Fuji).
Lipid content of adipocytes was determined by a
modi¢ed method of Ramirez-Zacarias et al. [20].
Cells were grown in 12-well multiwell dishes and
after washing with PBS, ¢xed with 0.5 ml glutaral-
dehyde (3% in PBS) for 1 h at room temperature.
After successive washing with water and 60% isopro-
panol (0.5 ml each), cells were stained with O red oil
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(0.2% w/v in 60% isopropanol) for 2 h (under con-
stant gentle agitation). Cells were then washed again
successively with 60% isopropanol (to eliminate ex-
cess colour solution) and water. Water was allowed
to evaporate (37‡C overnight) and the ¢xed cells
were destained with 0.5 ml 60% isopropanol twice
for 2 h (under constant gentle agitation). The super-
natant was pooled and absorbency was measured at
510 nM.
The amount of glycerol released into the medium
was determined as an index for lipolytic activity of
cells. Glycerol determination was performed using a
kit from Boehringer Mannheim as described [18].
Cytochrome c oxidase (COx) activity was used as
a marker enzyme of mitochondrial respiratory ca-
pacity. COx activity was measured polarographically
in homogenates from suspended cells. An aliquot of
the cell suspension was used for determination of cell
number [18].
2.3. Experimental set-up
Two types of experiments were performed to eval-
uate the e¡ect of chronic L3-adrenergic stimulation
on adipocyte function:
2.3.1. Dose response of CL action
At the third day of culture CL or isoproterenol
was added to the culture medium at concentrations
between 10311 and 1036 M as indicated in the ¢g-
ures. Cells were harvested at day 10 and analysed.
2.3.2. Time course of CL action
CL (1038 M) or isoproterenol (1035 M) were
added at the third culture day. These concentrations
were chosen because in dose response experiments
they proved to be the most e¡ective for chronic stim-
ulation experiments. Cells were harvested up to the
10th day as indicated in the ¢gures with subsequent
measurement of cell number, lipid content and UCP-
1 content.
2.4. Statistics
Values are indicated as means þ standard errors
(when at least four di¡erent cell cultures were per-
formed). Di¡erences between groups were assessed
by analysis of variance followed by Duncan’s test




Fig. 1 shows the e¡ect of chronic adrenergic stim-
ulation on the proliferation of white and brown pre-
adipocytes. In both cell types stimulation with iso-
proterenol ^ a general L-adrenoceptor agonist ^
resulted in an increased cell number from the sixth
culture day on. The e¡ect was slightly more pro-
nounced in brown preadipocyte cultures (35% in-
crease on day 8) than in white cultures (20% increase
on day 8). L3-AR stimulation through CL, however,
had no signi¢cant e¡ect on cell number either in
white or brown preadipocyte cultures. In brown pre-
adipocyte cultures a small but not signi¢cant increase
was observed.
Fig. 1. E¡ect of L-adrenergic stimulation on proliferation of
white and brown preadipocytes. Stromal vascular fraction of
WAT or BAT was plated at day 0. Cells were cultivated in
multiwell dishes in standard medium supplemented with either
10 nM CL or 10 WM isoproterenol. At indicated days after
plating cells were trypsinised and counted. Data are from two
independently performed cell cultures with a total n = 8. Data
are mean þ S.E. From day 4 (WAT) and day 6 (BAT) on, cell
cumber was signi¢cantly higher in isoproterenol-treated cul-
tures.
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3.2. Lipid accumulation and lipolysis
In both types of adipocyte culture lipid accumula-
tion was ¢rst detectable at day 6, i.e., around con-
£uence (Fig. 2). Until day 10 an almost linear in-
crease in lipid content occurred. However, overall
lipid accumulation was about 30% higher in white
adipocyte cultures than in brown ones, con¢rming
previous ¢ndings [18]. Chronic treatment with either
isoproterenol or CL resulted in a decreased lipid ac-
cumulation in both cell types, due to their lipolytical
action. This e¡ect was the same for isoproterenol and
CL treatment. The dose response of the lipolytical
action of CL is shown in Fig. 3. At a concentration
of 10 nM CL had the maximum e¡ect on lipolysis in
white as well as in brown adipocyte cultures. The
higher glycerol release observed in white cultures is
probably due to the higher overall lipid content of
white adipocyte cultures (see Fig. 2).
3.3. Thermogenic properties
The thermogenic property of brown adipocytes is
evident (i) by a high mitochondrial density and (ii)
by the expression of the brown fat speci¢c uncou-
pling protein (UCP-1). The e¡ect of isoproterenol
and CL on UCP-1 expression detected by Western
blot is shown in Fig. 4. Only a faint signal at day 10
could be detected in white preadipocyte cultures fol-
lowing chronic treatment with either isoproterenol or
CL. In brown preadipocyte cultures however, from
day 7 on adipocytes showed a signi¢cant increase in
UCP-1 with highest levels around day 9 and 10. Iso-
proterenol increased UCP-1 six times and CL even
ten times over control levels. The dose response ex-
periment (Fig. 5) shows that 10 nM CL was the most
Fig. 2. E¡ect of L-adrenergic stimulation on lipid accumulation
of white and brown preadipocytes during di¡erentiation. Cells
were cultivated and treated as in Fig. 1. Lipid accumulation
was measured using O red oil staining of neutral lipids. Data
are from two independently performed cell cultures with a total
n = 8. Data are mean þ S.E. When error bar is not visible it is
within symbol size. From day 7 on, in both WAT and BAT
cultures the lipid content was signi¢cantly higher than in con-
trol cultures.
Fig. 3. E¡ect of CL on lipolytic activity in white and brown
adipocytes. Cells were chronically treated with CL at indicated
concentrations. At day 10 of culture, glycerol content was de-
termined in culture medium. Data are from two independently
performed cell cultures witha total n = 6. Data are mean þ S.E.
Fig. 4. E¡ect of L-adrenergic stimulation on UCP-1 content in
white and brown preadipocytes during di¡erentiation. Cells
were cultivated and treated as in Fig. 1. UCP-1 content was
measured by immunoblotting of total cell homogenates. Data
are means from two independently performed cell cultures.
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e¡ective concentration, as already shown on lipolysis
(Fig. 3).
Levels of UCP-1 and UCP-2 mRNA expression
(on day 10 of culture) are shown in Table 1. UCP-
1 mRNA expression was much lower in WAT than
in BAT culture. CL and isoproterenol lead to a sim-
ilar 10^13-fold increase compared to basal levels in
white as well as in brown adipocyte cultures. UCP-2
mRNA levels were almost identical in WAT and
BAT control cultures and increased by L-AR ago-
nists, although more strongly in BAT than in WAT
cultures.
Mitochondrial activity as assessed by COx activity
was about twofold higher in brown preadipocyte cul-
tures than in white cultures (Fig. 6). However, in
both cell types it could not be increased by chronic
stimulation with either isoproterenol or CL even at
highest concentrations. Mitochondrial biogenesis was
thus not stimulated by L-adrenergic agonists in vitro.
4. Discussion
Treatment of animals with a L3-AR agonist has
profound e¡ects on overall energy metabolism [9^
14,21,22] which are apparently mediated by its action
on white as well as brown adipose tissue [16]. Inter-
pretation of in vivo studies is often di⁄cult in respect
to local peripheral drug action. In vitro studies using
immortalised cell lines, on the other hand, are often
far from the physiological situation. We therefore
have developed a parallel primary cell culture system
of white and brown preadipocytes from the same
animal, which allows the study of white and brown
preadipocyte di¡erentiation and metabolism [2,18].
Here we studied the e¡ect of chronic L3-AR stimu-
lation on proliferation and parameters of functional
di¡erentiation of white and brown preadipocytes us-
ing the speci¢c agonist CL 316,243.
Fig. 5. E¡ect of CL on UCP-1 content in white and brown adi-
pocytes. Cells were chronically treated with CL at indicated
concentrations. At day 10 of culture, UCP-1 content was mea-
sured by immunoblotting of total cell homogenates. Data are
means from two independently performed cell cultures.
Table 1
Gene expression of UCP-1 and UCP-2 in white and brown adi-
pocyte cultures
Cell type Treatment UCP-1 UCP-2
WAT ^ 1 1
WAT CL 316,423 13.6 3.0
WAT Isoproterenol 10.8 5.0
BAT ^ 7.7 1.0
BAT CL 316,423 82.6 6.5
BAT Isoproterenol 92.2 9.0
Cells were treated with CL 316,423 (0.1 WM) or isoproterenol
(10 WM) from day 3 on, and harvested on day 10 of culture for
Northern blot analyses. Signals were quanti¢ed using a phos-
phoimager and expressed relative to expression in WAT control
cultures. Data are means from two independently performed
cell cultures.
Fig. 6. E¡ect of L-adrenergic stimulation on mitochondrial res-
piratory capacity of white and brown adipocytes. Cells were
chronically treated with isoproterenol or CL at indicated con-
centrations. At day 10 of culture, cytochrome c oxidase activity
was measured in total cell homogenates. Data are from two in-
dependently performed cell cultures with a total n = 6. Data are
mean þ S.E. When error bar is not visible it is within symbol
size.
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An in vivo recruitment of brown adipocytes upon
treatment with noradrenaline has been known for
many years [23]. Noradrenaline also has a stimula-
tory e¡ect on DNA synthesis of brown adipocytes in
primary cultures in vitro, which was shown to be
mediated by L1-ARs rather than L3-ARs [24,25].
This is con¢rmed by our present study using a di¡er-
ent primary culture system (hamster rather than
mouse). However, surprisingly we found that also
white preadipocyte proliferation was stimulated by
isoproterenol in very much the same manner (Fig.
1). This means that the mitogenic e¡ect of catechol-
amines on preadipocyte proliferation is not a unique
feature of BAT as proposed before [23]. To our
knowledge, this is the ¢rst report of a L-AR-stimu-
lated proliferation of white preadipocytes. It would
be of interest to further elucidate the molecular
mechanism underlying the exclusively L1-AR-medi-
ated mitogenic e¡ect. It is most probably not due
to a lack of L3-ARs in preadipocytes. In brown pre-
adipocytes we could detect L3-AR mRNA in non-
di¡erentiated cells early in primary culture, although
its expression was largely increased throughout dif-
ferentiation [26]. In a recent study on mouse brown
preadipocytes di¡erentiated in primary cell culture,
Bronnikov et al. [25] observed a switch in the control
of cAMP production from L1 to L3 adrenoceptors
during preadipocyte di¡erentiation. They propose
that in brown preadipocytes only the L1-AR is
coupled to cAMP production which subsequently
promotes proliferation. Contrary to this, using rat
brown preadipocyte primary cultures, Chaudry and
Granneman [27] observed a di¡erential regulation of
functional response by L1- and L3-ARs, respectively.
In a previous study the same authors had already
found evidence that the L3-AR interacts with both
Gs and Gi proteins, contrary to the L1-AR which
couples predominantly to Gs [28]. They therefore
suggest that the two L-ARs are di¡erentially coupled
to G proteins and adenylyl cyclase subtypes [27].
This is also supported by data of Soeder et al. who
report an activation of MAP kinase by the L3-AR
through a Gi protein-dependent mechanism, and
therefore also suggest that the L3-AR might display
a dual Gs/Gi protein coupling [29].
White adipose tissue usually has a higher lipid
content than brown adipose tissue [1], which is re-
£ected by a higher degree of lipid accumulation in
cultured white adipocytes compared with brown adi-
pocytes [18]. This was con¢rmed by the present
study, showing a 30% higher lipid content per cell
in WAT compared with BAT cultures, although cul-
ture conditions were exactly the same (Fig. 2). This
further corroborates our hypothesis that preadipo-
cytes from the stromal vascular fraction white and
brown adipose tissue are already determined in their
di¡erentiation pathway [2,18]. Chronic exposure to
either isoproterenol or CL signi¢cantly reduced the
lipid content to the same extent in both culture types,
due to their lipolytic activity, but could not com-
pletely inhibit lipid accumulation. The dose response
(Fig. 3) showed maximum lipolytic activity of CL at
10 nM both in WAT and BAT cultures, which is
within the range observed in rat brown preadipocyte
cultures [27]. The lower glycerol release from BAT
cultures as compared to WAT cultures could be due
to the lower lipid content of brown adipocytes.
Because the thermogenic capacity of brown adi-
pose tissue is closely correlated to the amount of
UCP-1 [30], we consider quanti¢cation of UCP-1
rather than its mRNA as a more appropriate indica-
tor of thermogenic capacity. We have shown previ-
ously that both insulin and T3 are required for max-
imum ‘basal’ UCP-1 expression in brown adipocytes
[18]. Here we investigated the additional e¡ect of L-
AR stimulation. As evident from Figs. 4 and 5, an
over 10-fold increase in UCP-1 content was induced
by chronic CL treatment of BAT cultures, isoproter-
enol leading to an over 6-fold increase. This is in
good accordance with changes in UCP-1 mRNA lev-
els, which were 10^12-fold increased (Table 1). How-
ever, despite of chronic treatment from day 3 on,
UCP-1 expression was restricted to di¡erentiated adi-
pocytes. This is in accordance with a previous study
where we showed that di¡erentiation of brown pre-
adipocytes is at least a two-step process with physio-
logically discriminable cell types [31]. Maximum
stimulation of UCP-1 expression was observed at
10 nM (Fig. 5), i.e., at the same concentration which
showed maximum e¡ect on lipolysis (Fig. 3). This is
somewhat in contrast to data by Chaudry and Gran-
neman, who found CL several times more potent in
stimulating lipolysis than in inducing UCP-1 gene
expression [27]. However, in their study they inves-
tigated short-term, i.e., acute e¡ects of CL on mature
brown adipocytes not previously exposed to CL,
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whereas we studied the e¡ect of chronic exposure to
L-AR agonists.
It must be noted that a residual expression of
UCP-1 (mRNA and protein) was also observed in
WAT cultures (Table 1, Figs. 4 and 5). In a previous
study we have shown that approximately 10^15% of
adipocytes in WAT cultures show expression of
UCP-1 [18]. Apparently there is a certain ‘contami-
nation’ with brown preadipocytes in the WAT stro-
mal vascular fraction. These cells di¡erentiate into
brown adipocytes which can be stimulated to in-
crease UCP-1 expression. This means that the in-
crease in UCP-1 observed in WAT cultures is due
to an increased expression within this fraction of
brown adipocytes. Immunohistochemical evidence
showed clearly that the number of UCP-1 expressing
cells did not increase after L-adrenergic stimulation
([18]; Encke et al., unpublished observations).
UCP-2 is one of the new members of the uncou-
pling protein family which is abundantly expressed in
many tissues including white fat [32]. Here we ¢nd
basal expression levels of UCP-2 almost identical in
BAT and WAT cultures (Table 1). This is in accor-
dance with data in vivo where UCP-2 mRNA levels
of WAT could even exceed BAT levels [32]. There
are controversial reports on the ability of L-AR ago-
nists to increase UCP-2 mRNA: in particular, L3-AR
treatment failed to induce UCP-2 in several in vivo
studies in either white or brown fat, whereas others
found an increase (for an overview see [32]). How-
ever, UCP-2 gene expression could be stimulated by
cAMP analogues in 3T3-L1 white adipocytes [33]
which is in accordance with our ¢ndings. The phys-
iological function of UCP-2 is still unknown. UCP-2
knock-out mice do not become obese and have a
normal response to cold exposure or high-fat diet
[34]. Interestingly, they proved to be resistant against
infection with Toxoplasma gondii which indicates a
role for UCP-2 in macrophage-mediated immunity
[34]. However, the high expression of UCP-2 in white
fat, which can be even higher than in brown fat [32],
is not understood thus far.
One important di¡erence between white and
brown adipocytes is the higher respiratory capacity,
i.e., mitochondrial density of brown adipocytes. Cold
exposure does not only increase UCP-1 expression
but also the respiratory capacity, i.e., the amount
of mitochondria in BAT [35]. This di¡erence is ^
although to a lesser extent ^ persistent in brown
and white adipocytes di¡erentiated in vitro (Fig. 6,
[18]). In the present study COx activity of di¡erenti-
ated BAT cultures was consistently about twofold
higher than that of WAT cultures. However, as
shown in Fig. 6, neither isoproterenol nor CL could
mimic in vitro the stimulatory e¡ect of cold exposure
on mitochondriogenesis in brown or white adipo-
cytes. This is in contrast with results obtained in
vivo, where chronic infusion of CL in rats increased
COx activity not only in brown fat but also in white
fat depots [17]. A possible explanation is that the
e¡ect of CL on mitochondrial biogenesis is not a
direct one but involves other mediator(s). It is also
possible that in our cell culture conditions an essen-
tial component is missing. However, it is clear from
our data that induction of UCP-1 and mitochondrial
proliferation does not entirely depend on the same
cellular signal transduction pathways.
Although di¡erentiation of white adipocytes has
been extensively studied (for reviews see [36^38]),
much less is known about molecular mechanisms of
brown adipocyte di¡erentiation [39]. Here we have
shown evidence that proliferation of brown as well
as white preadipocytes is stimulated through L-ad-
renergic pathways not involving the L3-AR receptor.
We suggest that although white and brown preadi-
pocytes in primary culture display similar pheno-
types, they nevertheless represent di¡erent cell types
as evident from their di¡erent functional di¡erentia-
tion. Furthermore, L-adrenergic stimulation in vitro
is not su⁄cient to mimic the in vivo physiological
adaptation of BAT to cold exposure.
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